Get started
Author

Frederick Faßlrinner

Observed names: F. Fasslrinner, Frederick Fasslrinner
ORCID: 0000-0002-0057-1802
Observed ORCID: 0000-0002-0057-1802
OpenAlex ID: A5077367487
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial
2018 · Frederick Fasslrinner, Johannes Schetelig, et al. · The Lancet Haematology · 92
Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
2020 · Claudia Arndt, Frederick Fasslrinner, et al. · Cancers · 69
PDF
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
2020 · Claudia Arndt, Liliana R. Loureiro, et al. · OncoImmunology · 40
PDF
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
2021 · Enrico Kittel-Boselli, Karla Elizabeth González Soto, et al. · Cancers · 34
Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cells
2012 · Frederick Faßlrinner, Manja Wobus, et al. · Experimental Hematology · 27
PDF
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
2024 · Russell Towers, Lidia Trombello, et al. · Cancer Immunology Immunotherapy · 20
PDF
Midostaurin abrogates CD 33‐directed Uni CAR and CD 33‐ CD 3 bispecific antibody therapy in acute myeloid leukaemia
2019 · Frederick Fasslrinner, Claudia Arndt, et al. · British Journal of Haematology · 17
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management
2022 · Claudia Arndt, Ralf Bergmann, et al. · Cancers · 16
PDF
Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma
2019 · Frederick Fasslrinner, Friedrich Stölzel, et al. · Transplantation and Cellular Therapy · 13
FLT3 ‐directed UniCAR T‐cell therapy of acute myeloid leukaemia
2023 · J. C. Peschke, R. Bergmann, et al. · British Journal of Haematology · 9
PDF
Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
2022 · Nicola Mitwasi, Claudia Arndt, et al. · International Journal of Molecular Sciences · 6
PDF
Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis
2021 · Alberto Farina, Federico Moro, et al. · Pharmacology Research & Perspectives · 4
Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules
2019 · Frederick Fasslrinner, Claudia Arndt, et al. · Blood · 3
Strength of clinical evidence leading to approval of novel cancer medicines in Europe: a systematic review and data synthesis.
2024 · alberto farina, Federico Moro, et al.
PDF
Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial
2017 · Frederick Faßlrinner, Johannes Schetelig, et al. · Blood
Works count: 15
Citation count: 350
H-index: 9
I10-index: 9
Year
Topic
Type